Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam.
Campylobacter jejuni
acute campylobacteriosis model
ampicillin plus sulbactam
broad-spectrum antibiotic treatment
differential gut microbiota depletion
enteropathogenic infection
host-pathogen interaction
microbiota-depleted IL-10-/- mice
Journal
European journal of microbiology & immunology
ISSN: 2062-509X
Titre abrégé: Eur J Microbiol Immunol (Bp)
Pays: Hungary
ID NLM: 101569896
Informations de publication
Date de publication:
07 Sep 2022
07 Sep 2022
Historique:
received:
01
08
2022
accepted:
19
08
2022
entrez:
7
9
2022
pubmed:
8
9
2022
medline:
8
9
2022
Statut:
aheadofprint
Résumé
Gut microbiota depletion is a pivotal prerequisite to warrant Campylobacter jejuni infection and induced inflammation in IL-10-/- mice used as acute campylobacteriosis model. We here assessed the impact of an 8-week antibiotic regimen of ampicillin, ciprofloxacin, imipenem, metronidazole, and vancomycin (ABx) as compared to ampicillin plus sulbactam (A/S) on gut microbiota depletion and immunopathological responses upon oral C. jejuni infection. Our obtained results revealed that both antibiotic regimens were comparably effective in depleting the murine gut microbiota facilitating similar pathogenic colonization alongside the gastrointestinal tract following oral infection. Irrespective of the preceding microbiota depletion regimen, mice were similarly compromised by acute C. jejuni induced enterocolitis as indicated by comparable clinical scores and macroscopic as well as microscopic sequelae such as colonic histopathology and apoptosis on day 6 post-infection. Furthermore, innate and adaptive immune cell responses in the large intestines were similar in both infected cohorts, which also held true for intestinal, extra-intestinal and even systemic secretion of pro-inflammatory cytokines such as TNF-α, IFN-γ, and IL-6. In conclusion, gut microbiota depletion in IL-10-/- mice by ampicillin plus sulbactam is sufficient to investigate both, C. jejuni infection and the immunopathological features of acute campylobacteriosis.
Identifiants
pubmed: 36069779
doi: 10.1556/1886.2022.00014
pmc: PMC9530677
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Infect Dis. 2014 Aug;14(8):742-750
pubmed: 25022435
Front Cell Infect Microbiol. 2014 Jun 10;4:77
pubmed: 24959425
Curr Opin Infect Dis. 2007 Oct;20(5):514-8
pubmed: 17762786
Microbiol Rev. 1986 Mar;50(1):81-94
pubmed: 3515146
Peptides. 2018 Mar;101:1-9
pubmed: 29288684
J Infect Dis. 2010 Jan 15;201(2):223-32
pubmed: 20001600
Microorganisms. 2020 Mar 28;8(4):
pubmed: 32231139
Infect Immun. 2006 Sep;74(9):5261-71
pubmed: 16926420
Eur J Microbiol Immunol (Bp). 2016 Dec 01;6(4):253-271
pubmed: 27980855
J Trop Pediatr. 2001 Jun;47(3):176-8
pubmed: 11419683
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4557-76
pubmed: 25197329
Gut. 1985 Sep;26(9):945-51
pubmed: 4029720
Eur J Microbiol Immunol (Bp). 2013 Sep;3(3):174-82
pubmed: 24265935
Contrib Microbiol. 2001;8:150-65
pubmed: 11764732
Clin Dev Immunol. 2013;2013:526860
pubmed: 24324507
PLoS One. 2011;6(6):e20953
pubmed: 21698299
Microbiology (Reading). 1997 Jan;143 ( Pt 1):5-21
pubmed: 9025274
Curr Top Microbiol Immunol. 2021;431:1-23
pubmed: 33620646
Front Immunol. 2017 Apr 19;8:397
pubmed: 28469619
J Immunol. 2006 Dec 15;177(12):8785-95
pubmed: 17142781
Gut. 2007 Jul;56(7):941-8
pubmed: 17255219
PLoS One. 2012;7(7):e40761
pubmed: 22808254